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Hepatitis delta virus (HDV) is a small, defective RNA virus that can infect only individuals carrying
hepatitis B virus. HBV/HDV co-infection results in more severe liver disease than HBV single infec-
tion and more rapid progression to cirrhosis and hepatocellular carcinoma (HCC). The epigenetic
events involved in hepatocyte transformation towards malignancy in this context are poorly known.
Here we report that, in Huh-7 cells, HDV induces DNMT3b expression and is associated to E2F1 tran-
scription factor hypermethylation. Moreover our cell cycle analysis showed that HDV induces G2/M
arrest. These ﬁndings suggest that HDV could play a role in HCC development at least in part by alter-
ing DNAmethylation events. A better understanding of the molecular mechanisms involved in HDV-
related carcinogenesis could help to identify new therapeutic targets.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction genes (TSGs) [8]. Proteomic analyses of Huh-7 hepatocellular carci-Hepatitis delta virus (HDV) consists of a circular single-stranded
RNA genome of 1679 nucleotides which assembles two viral
proteins (HDAg-L and HDAg-S) but does not encode its own poly-
merase, instead, employing a cellular enzyme for its replication
[1]. HDV transmission requires the hepatitis B virus (HBV) surface
antigen (HBsAg), [2,3] which is the reason why this defective virus
infects only individuals in the presence of hepatitis B virus [4].
Chronic HDV replication enhances liver damage relative to HBV
alone leading to cirrhosis and hepatocellular carcinoma (HCC) at an-
nual rates of 4% and 2.8%, respectively [5]. Themechanism(s) behind
this enhancement is currently unknown. Tumor suppressor gene
silencing through aberrant addition of methyl groups to speciﬁc
regions of the DNA such as CpG islands is a frequent epigenetic
event in HCC [6]. The transfer of methyl groups to the DNA is cata-
lyzed by DNA methyltransferases (DNMTs). Among those DNMT1
and DNMT3b are also transiently recruited to DNA break sites [7].
HCC development is a multistep process with accumulation of
genetic and epigenetic alterations in regulatory genes, leading to
activation of oncogenes and inactivation or loss of tumor suppressornoma cells transfected with HDV RNA, HDAg-S, or HDAg-L have
shown that at least 32 proteins display differential expression in
the presence of HDV components [9]. These dysregulated proteins
are known to be involved in different cellular processes such as
nucleic acid metabolism, protein metabolism, cellular transport,
signal transduction, apoptosis, and cell growth. However, how
HDAgs regulate host cell mechanisms of epigenetic control of gene
expression remains poorly understood. Up to date, the ability of
some viruses in inducing the methylation of host DNA is well docu-
mented [10–12]. In the present study we evaluated the expression
levels of the DNA methyltransferases DNMT1 and 3b in an attempt
to elucidate these molecular mechanisms using an in vitro model
the humanhepatoma cell line (Huh-7) expressing theHDVantigens.
Moreover we evaluated the methylation levels of 24 genes involved
in HCC development in order to ﬁnd out a possible role for the ob-
served DNMT3b overexpression. A better understanding of the
interaction between HDV and the epigenetic host cell machinery
can provide new insights for antiviral strategies or new therapeutic
targets to prevent HDV-associated HCC.2. Materials and methods
2.1. Plasmids, antibodies, and chemicals
Plasmid pSVL(D3) (kindly donated by John M. Taylor, Fox Chase
Cancer Center, Philadelphia, PA) contains three copies of the
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vector pSVL (Pharmacia, Uppsala, Sweden). The antibody that rec-
ognizes both small and large HDV antigen (HDAg-S and HDAg-L),
also provided by John M. Taylor, Fox Chase Cancer Center, Philadel-
phia, PA, was raised in rabbits by inoculation of HDAg expressed in
Escherichia coli. Rabbit polyclonal antibodies directed against
STAT3 and its phosphorylated form, DNMT1, DNMT3b, were pur-
chased from Cell Signaling Technology, Inc. (Euroclone, Milan).
Mouse monoclonal antibody b-actin (clone Ac74) was from Sig-
ma–Aldrich (Steinheim, Germany). STAT3 inhibitor (NSC74859)
was obtained from Merck Chemicals Inc. (Milan, Italy).
2.2. Cell culture and transfection
Human hepatoma cells (Huh-7) were maintained in Dulbecco’s
modiﬁed Eagle’s medium supplemented with 10% fetal bovine ser-
um, 100 U/ml penicillin, and 100 ng/ml streptomycin (all products
were from Invitrogen, Milan, Italy). Subconﬂuent cultures of Huh-7
cells were transfected using lipofectamine 2000 (Invitrogen, Milan,
Italy) and incubated at 37 C with Opti-MEM medium for 6 h in a
humidiﬁed, 5% CO2 incubator. The medium was then replaced with
Dulbecco’s modiﬁed Eagle’s medium containing 10% fetal bovine
serum without antibiotics, and transfected cells were incubated
for another 9 days, with medium changes every second day.
2.3. Indirect immunoﬂuorescence (IFL)
We ﬁxed Huh-7 cells, plated and transfected on coverslips, for
10 min in 4% paraformaldehyde at room temperature and perme-
abilized them with 0.2% Triton X-100 for 2 min. We washed the
coverslips three times in phosphate-buffered saline solution
(PBS) and incubated themwith anti-HDAg (1:100 in PBS) overnight
at 4 C. After three washes in PBS, cells were incubated for 1 h at
room temperature with rhodamine labeled anti-rabbit antibodies
(Jackson Lab) diluted at 1:100. After rinsing three times in PBS, cov-
erslips were mounted on microscope slides using Vectashield H1-
200 (DBA Milan, Italy). For ﬂuorescence microscopy, slides
mounted for immunoﬂuorescence were observed using a Nikon
Eclipse E600 microscope. Percentages of HDAg-positive or HDAg-
negative cells over total cells were calculated by counting >200
cells in randomly selected ﬁelds.
2.4. RNA isolation and quantitative real-time polymerase chain
reaction
Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Mi-
lan, Italy) and subsequently treated with deoxyribonuclease I.
Quantitative real time PCR was performed starting from 50 ng of
puriﬁed RNA using the one step quantifast SYBR Green RT PCR
KIT (Qiagen). For real-time polymerase chain reaction (PCR), the
following Human SYBR Green QuantiTect Primer Assays (all pur-
chased from Qiagen) were used: human DNMT1 (QT00034335),
human DNMT3b (QT00032067) and human E2F1 (QT00016163).
Reactions were set up in 96-well plates using a 7700HT Real-Time
PCR System (Applied Biosystems, Foster City, CA), and all samples
were assayed in triplicate. Optical data obtained were analyzed
using the default and variable parameters available in the SDS soft-
ware package (version 1.9.1; Applied Biosystems, Foster City, CA).
Expression levels of target gene were normalized using the house-
keeping control genes: TATA binding protein (TBP, QT00000721).
2.5. Immunoblot analysis
For total protein extracts, cells were washed once with ice-cold
phosphate-buffered saline (PBS) and scraped from culture dishes in
the presence of lysis buffer (50 mM Tris–HCl, pH 6.8, 100 mMdithiothreitol, 2% sodium dodecyl sulfate, 0.1% bromophenol blue,
10% glycerol) supplemented with protease inhibitor cocktail
(COMPLETE; Roche Diagnostics, Mannheim, Germany), 1 mM phe-
nylmethylsulphonyl ﬂuoride and 1 mM sodium orthovanadate.
Equal amounts of protein extracts were run on 10% sodium dodecyl
sulfate–polyacrylamide gel electrophoresis gels and electroblotted
onto nitrocellulose (Whatman, Dassel, Germany). Membranes
were blocked for 1 h at room temperature with PBS containing
0.1% (vol/vol) Tween 20 and 5% (wt/vol) non-fat milk powder be-
fore the overnight incubation at 4 C with the above primary anti-
bodies in blocking solution. After three washes with blocking
buffer, the membranes were incubated for 90 min at room temper-
ature with horseradish peroxidase–conjugated goat anti-mouse or
goat antirabbit secondary antibodies (BioRad, Hercules, CA) diluted
1:4000. Membranes were washed extensively with washing solu-
tion and antigen–antibody complexes were detected by enhanced
chemiluminescence (ECL; Amersham Biosciences) and the signal
was detected on an X-ray ﬁlm (Amersham Biosciences) according
to the manufacturer’s instructions. For quantitative measurement,
ﬁlms were scanned by densitometry and the spots corresponding
to proteins were analyzed by using the Image J software.
2.6. EpiTect Methyl Signature qPCR Array
DNA extracted from Huh-7 control cells and from those trans-
fected with pSVL(D3) were used to perform the EpiTect Methyl Sig-
nature qPCR Array (cat. no. MEAH-031A-12 Sabiosciences, Milan
Italy) following the manufacture instructions. Brieﬂy 1 lg of DNA
was subjected to a digestion with methylation sensitive or methyl-
ation-dependent restriction enzyme. These enzymes will digest the
unmethylated and methylated DNA, respectively. Following diges-
tion, the remaining DNA is quantiﬁed by real-time PCR in each
individual enzyme reaction using primers that ﬂank the promoter
(gene) region of interest. The relative fractions of hypermethylated,
intermediately methylated and unmethylated DNA are subse-
quently determined by comparing the amount in each digest with
that of a mock (no enzymes added) digest.
2.7. Cell cycle analysis
Cells were harvested the day before the experiment and ﬁxed
with 70% cold ethanol over night at 20 C. After centrifugation
at 2000 rpm for 5 min cells were washed twice with PBS and RNase
I was added at concentration of (100 lg/ml). Finally cells were
stained with propidium iodide (PI) (50 lg/ml in PBS) before load-
ing on TALI Image Cytometer (LifeTechnologies, Milan, Italy). Re-
sults are expressed as mean and S.E.
2.8. Statistics
Results were expressed as means ± S.E.M. For statistical com-
parison, signiﬁcance was evaluated using the Student t test. Values
of P < 0.05(⁄) and P < 0.005(⁄⁄) or P < 0.001 (⁄⁄⁄) were considered
statistically signiﬁcant.
3. Results
3.1. DNMT1, DNMT3b expression levels in HDV expressing cells
To investigate whether HDV modulates DNA methyltransfer-
ases (DNMTs) expression, we reproduced an in vitro system that
was reported to allow HDV replication [13]. Huh-7 cells were
transfected with pSVL(D3) plasmid coding for HDAg-S and HDAg-
L and, at regular intervals of 3-6-9 days, proteins were extracted
and examined by immunoblot analysis for the presence of the
two HDAg isoforms (Fig. 1A). The efﬁciency of transfection was
Fig. 2. Immunoblot detection of DNMT1, DNMT3b, and STAT3 proteins and its
phosphorylation at Tyr705 residue in mock and pSVL(D3) expressing cells (A). After
9 days from transfection, cells were lysed and an equal amount of proteins were
loaded on 10% polyacrylamide gel and separated by electrophoresis and immuno-
blotted with the respective antibodies normalized to b-actin expression as loading
control. (B) Quantiﬁcation plot of DNMT1, 3b, phSTAT3 and STAT3 normalized to b-
actin.
Fig. 3. DNMT3b mRNA expression levels by qRealTime PCR in mock and pSVL(D3)
expressing cells before and after treatment with STAT3 inhibitor (NSC74859) at
concentration of 100 lM for the last 48 h of transfection (A). Immunoblot detection
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to approximately 45% as determined by counting HDAg-positive
cells under the ﬂuorescence microscope in six randomly selected
ﬁelds (Fig 1B). Only 9 days post transfection both antigens were
expressed and for this reason all the subsequent experiments were
performed at this time point. We then evaluated DNMT1 and 3b
levels in HDV expressing cells in order to better understand a pos-
sible role of HDV in HCC-associated epigenetic alteration. DNMT3b
mRNA and protein expression resulted upregulated upon HDV
transfection by quantitative real time PCR (and immunoblot detec-
tion (HDV vs mock P = 0.01) (Figs. 1 and 2). No changes were ob-
served for DNMT1 mRNA and protein expression levels.
3.2. STAT3 inhibition decreases DNMT3b expression
As it was reported that large delta antigen activates the signal
transducer and activator of transcription 3 (STAT3) [28] and that
STAT3 is involved in the regulation of DNMT1 expression [14] we
evaluated STAT3 phosphorylation in pSVL(D3) transfected cells.
Noteworthy, as shown in Fig. 2, phosphorylation at Tyrosine
705 residue of STAT3 protein and its total form resulted increased
in HDV overexpressing cells. In order to test whether STAT3 is
responsible for DNMT3b overexpression we measured its mRNA
and protein levels upon treatment with the STAT3 inhibitor
NSC74859 in Huh-7 cells expressing the HDV antigens. As it is
shown in Fig. 3A and B, DNMT3b was signiﬁcantly decreased after
treatment with NSC either in mock or HDV transfected cells at the
mRNA and protein levels, suggesting that HDV induces DNMT3b
upregulation through STAT3 in Huh-7 cells. On the other hand no
effect of NSC treatment on DNMT1 expression was observed (data
not shown) and the reason of this discrepancy could rely on the
different type of cell cultures used in these different studies.
3.3. E2F1 hypermethylation and cell cycle analysis in Huh-7 cells
expressing HDV
As altered promoter methylation of tumor suppressor genes is
frequently found in HCC, we then sought to perform a methylation
proﬁle of 24 genes involved in HCC using the EpiTect Methyl Signa-
ture qPCR Array in Huh-7 cells expressing HDVAg as compared toFig. 1. Huh-7 cells were transfected with pSVL(D3) and the expression of the two
isoforms of the HDV antigen was analyzed at 3, 6, and 9 days post-transfection by
immunoblot analysis (A). Immunoﬂuorescence detection of HDV antigens in Huh-7
cells at 9 days post transfection (B). Quantitative real time PCR analysis for mRNA
expression level of DNMT1 and DNMT3b in mock and pSVL(D3) expressing cells (C).
and DNMT3b proteins in mock and pSVLD3 expressing cells before and after
treatment with STAT3 inhibitor (NSC74859) at concentration of 100 lM for the last
48 h of transfection. b-Actin levels served as a loading control (panel B).control cells. Among the different genes investigated only E2F1 re-
sulted hypermethylated in the presence of HDV (Fig. 4A).
Since E2F1 family plays a crucial role in the control of cell cycle
[15], we then sought to perform a cell cycle analysis in Huh-7 cells
before and after HDV transfection. Fig. 4B shows that HDV in-
creases of almost 2-fold the percentage of the cells in G2/M phase
(26% ± 2 HDV vs 14% ± 1 mock, P = 0.01) and slightly reduces the
percentage of the cells in S phase as compared to mock cells
(65.5% ± 0.5 mock vs 54.5% ± 2 HDV P = 0.02) suggesting that
HDV induces G2/M cell cycle arrest.
3.4. Effect of azacytidine treatment on E2F1 expression in Huh-7
expressing the HDV antigens
In order to test whether E2F1 hypermethylation resulted in a
downregulation of the mRNA expression we analyzed the E2F1
expression by qRT-PCR. As expected the hypermethylated gene re-
sulted downregulated at the mRNA level in HDV expressing cells
(mock vs HDV P = 0.01) (Fig. 5B). We then tested whether by mod-
ulating DNMT3b, using a speciﬁc inhibitor (azacytidine), we would
be able to reverse the decreased mRNA expression of the selected
genes. First, a time-dose-dependent experiment to assess the effect
Fig. 4. Percentage of unmethylated (UM) and methylated (M) DNA of E2F1 promoter in Huh-7 cells expressing HDV antigens as compared to control cells quantiﬁed by
Sabioscience EpiTect Methyl Signature qPCR Array (A). Cell cycle analysis in HDV expressing cells as compared to control cells (B).
Fig. 5. Time-dose-dependent effect of azacytidine treatment on DNMT3b expression. The plot represents quantitative real-time PCR of cells treated at different time points
and at different concentrations (A). E2F1 mRNA expression in Huh-7 cells expressing HDV antigens before and after treatment with azacytidine at concentration of 10 lM for
48 h (B).
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Fig. 5A shows that 10 lM of azacytidine for 48 h signiﬁcantly
downregulated the DNMT3b expression in Huh-7 cells. Moreover,
azacytidine treatment signiﬁcantly recovered the E2F1 expression
(HDV vs HDV + aza p = 0.00). (Fig. 5B).
4. Discussion
Viruses are among the most important human carcinogens [16]
and their ability in inducing DNMTs expression for some of them is
already documented [17–21]. The mechanisms behind the activa-
tion of DNMTs are challenging due to lack of relevant reports on
the regulation of their expression [20]. To our knowledge this is
the ﬁrst report showing that HDV increases DNMT3b overexpres-
sion through STAT3 activation. Several tumours are characterized
by activated STAT3 protein [22,23] and STAT3 inhibitors are under
development for the treatment of certain cancers [24]. Constitutive
activation of STAT3 in disease indicates an imbalance of stimula-
tory and downregulatory pathways [25]. DNMTs are critical in epi-
genetic events through the addition of methyl groups to DNA.
Promoter hypermethylation mediated by DNMTs triggers the inac-
tivation of tumor suppressor genes (TSGs). Maintenance of methyl-ation pattern is achieved by DNMT1 function during DNA
replication while new or de novo methylation is primarily cata-
lyzed by DNMT3a and DNMT3b [26]. The latter may play an onco-
genic role during tumorigenesis, and its genetic variants have been
consistently associated with risk of several cancers including HCC
[27]. In our study we demonstrated that HDV antigens induced
DNMT3b expression and STAT3 increased phosphorylation. The
latter is in agreement with a previous study [28] where the authors
demonstrated that HDV large Antigen is responsible for STAT3 and
NF-kB activation via oxidative stress. We further demonstrated
that inhibition of STAT3 through NSC74859 treatment blocked
DNMT3b upregulation. In a previous study Mota et al., [9] per-
formed a proteome analysis using a different in vitro model of
Huh-7 stably expressing the HDV antigens. Although they did not
found overexpressed DNMT3 levels, when a computational analy-
sis of protein interactions was performed, they found a subset of
genes (NASP, TPI, and PABP2), previously reported to interact
through the euchromatic histone methyltransferase SETDB1 which
also interacts with de novo DNA methyltransferases DNMT3A and
DNMT3B promoting gene silencing in human cancers. Moreover
we found that E2F1 promoter was hypermethylated in Huh-7 cells
expressing HDV antigens. The E2F family plays a crucial role in the
1428 G. Benegiamo et al. / FEBS Letters 587 (2013) 1424–1428control of cell cycle and action of tumor suppressor proteins and is
also a target of the transforming proteins of small DNA [29,30] or
RNA tumor viruses [31]. This protein binds preferentially to retino-
blastoma protein pRB in a cell-cycle dependent manner. It can
mediate both cell proliferation and p53-dependent/independent
apoptosis [32]. Our cell cycle analysis showed that HDV induces
G2/M cell cycle arrest which is a common feature of a number of
viral infections [33]. In order to link cell cycle arrest to tumorigen-
esis, we speculate that it is possible that the infected hepatocyte
may acquire one or more mutations that allow it to escape G2
arrest and apoptosis and proceed through the cell cycle, providing
an apoptosis-resistant clone of cells with altered cell cycle regula-
tion as suggested by Kannan [34].
Recently, it has been reported that HDV exerts an epigenetic
control over hepatitis B virus transcription/replication activity
[35]. Whether the DNMTs plays a crucial role in the interaction be-
tween the HBV and HDV needs to be assessed. In conclusion,
knockdown of DNMTs could represent an alternative anticancer
strategy for the treatment of HCC as already suggested [36].
Advances in our understanding of the molecular basis of HDV-
induced malignancies, will help to identify new targets for future
therapies, contributing to reduce the burden of these diseases.
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